热休克蛋白27和N末端脑利钠肽前体水平与慢性肺源性心脏病分级及预后的关系
CSTR:
作者:
作者单位:

1.重庆市涪陵中心医院,心内科,重庆 400712;2.重庆市涪陵中心医院,肾内科,重庆 408099,重庆 400712;3.重庆市涪陵中心医院,中国人民解放军 第6905厂职工医院 心内科,重庆 400712

作者简介:

通讯作者:

陈兴玲,E-mail:760573143@qq.com;Tel:15095830459

中图分类号:

R541.5

基金项目:


Correlation of heat shock protein 27 and brain natriuretic peptide levels with chronic pulmonary heart disease patients
Author:
Affiliation:

1.Department of Cardiology, No. 6905 Staff Hospital of Chinese People's Liberation Army, Chongqing 400712, China;2.Department of Nephrology, Fuling Central Hospital, Chongqing 408099, China, No. 6905 Staff Hospital of Chinese People's Liberation Army, Chongqing 400712, China;3.Department of Cardiology, No. 6905 Staff Hospital of Chinese People's Liberation Army, Chongqing 400712, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨热休克蛋白27(HSP27)和N末端脑利钠肽前体(NT-proBNP)水平与慢性肺源性心脏病(以下简称慢性肺心病)的关系。方法 选取重庆市涪陵中心医院120例慢性肺心病患者(观察组)和100例年龄、性别相匹配正常人群(对照组)为研究对象。比较两组血清HSP27、NT-proBNP水平差异;比较不同心功能分级观察组患者血清HSP27、NT-proBNP水平;采用Logistic回归分析慢性肺心病患者死亡的影响因素;绘制受试者工作特征(ROC)曲线,分析HSP27、NT-proBNP和HSP27+NT-proBNP联合检测对慢性肺心病患者的预后价值。结果 观察组血清HSP27、NT-proBNP水平高于对照组(P <0.05);血清HSP27、NT-proBNP水平随NYHA心功能分级的升高而升高(P <0.05)。本组所有慢性肺心病患者均获得随访,死亡12例。死亡患者血清HSP27、NT-proBNP水平高于存活患者(P <0.05)。多因素Logistic回归分析显示,NYHA分级Ⅲ、Ⅳ级[R=1.521(95% CI:1.302,6.352)]、HSP27[R=2.353(95% CI:1.564,10.549)]和NT-proBNP[R=2.754(95% CI:1.513,12.356)]是慢性肺心病患者死亡的影响因素。血清HSP27、NT-proBNP和HSP27+NT-proBNP联合检测3种方式对慢性肺心病患者预后的AUC为0.723(95% CI:0.538,0.908)、0.859(95% CI:0.807,0.911)、0.876(95% CI:0.742,1.000),敏感性为70.37%、71.55%和77.78%,特异性为89.23%、89.23%和91.01%。结论 慢性肺心病患者血清HSP27、NT-proBNP水平升高,且与患者心功能分级和预后有关。

    Abstract:

    Objective To investigate the correlation of heat shock protein 27 (HSP27) and brain natriuretic peptide precursor (NT-proBNP) levels with chronic pulmonary heart disease (CPHD).Methods One hundred and twenty patients with CPHD disease (observation group) and 100 age- and sex-matched normal people were selected as the control group. The difference of serum HSP27 and NT-proBNP levels between the two groups observed, and the relationships of the levels of HSP27 and NT-proBNP with the cardiac function classification and prognosis of CPHD patients were analyzed.Results The levels of serum HSP27 and NT-proBNP in the observation group were higher than those in the control group (P < 0.05). The levels of serum HSP27 and NT-proBNP increased with the increase of NYHA cardiac function grade (P < 0.05). Follow-up was performed on all patients with CPHD in this group, and 12 died. The serum levels of HSP27 and NT-proBNP in the death group were higher than those in the survival group (P < 0.05). Multivariate logistic regression analysis showed that NYHA grade III and IV [R = 1.521 (95% CI: 1.302, 6.352)], HSP27 [R = 2.353 (95% CI: 1.564, 10.549)], and NT-proBNP [R = 2.754 (95% CI: 1.513, 12.356)] were the influencing factors of death in patients with CPHD. The AUC was 0.723 (95% CI:0.538,0.908), 0.859 (95% CI:0.807,0.911), and 0.876 (95% CI:0.742,1.000), and the sensitivity and specificity were 70.37%, 71.55%, 77.78%, 89.23%, 89.23%, 91.01%, respectively.Conclusion The levels of HSP27 and NT-proBNP were significantly increased in CPHD patients, and were closely related to the cardiac function and prognosis.

    参考文献
    相似文献
    引证文献
引用本文

蓝运竞,陈兴玲,葛利珍,向立权.热休克蛋白27和N末端脑利钠肽前体水平与慢性肺源性心脏病分级及预后的关系[J].中国现代医学杂志,2021,(17):85-90

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-12-07
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-10-31
  • 出版日期:
文章二维码